In Vitro Polymerization of Tau Protein Monitored by Laser Light Scattering:  Method and Application to the Study of FTDP-17 Mutants

Tau polymerization into the filaments that compose neurofibrillary tangles is seminal to the development of many neurodegenerative diseases. It is therefore important to understand the mechanisms involved in this process. However, a consensus method for monitoring tau polymerization in vitro has bee...

Full description

Saved in:
Bibliographic Details
Published inBiochemistry (Easton) Vol. 39; no. 20; pp. 6136 - 6144
Main Authors Gamblin, T. Chris, King, Michelle E, Dawson, Hana, Vitek, Michael P, Kuret, Jeff, Berry, Robert W, Binder, Lester I
Format Journal Article
LanguageEnglish
Published United States American Chemical Society 23.05.2000
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Tau polymerization into the filaments that compose neurofibrillary tangles is seminal to the development of many neurodegenerative diseases. It is therefore important to understand the mechanisms involved in this process. However, a consensus method for monitoring tau polymerization in vitro has been lacking. Here we demonstrate that illuminating tau polymerization reactions with laser light and measuring the increased scattering at 90° to the incident beam with a digital camera results in data that closely approximate the mass of tau polymer formation in vitro. The validity of the technique was demonstrated over a range of tau concentrations and through multiple angle scattering measurements. In addition, laser light scattering data closely correlated with quantitative electron microscopy measurements of the mass of tau filaments. Laser light scattering was then used to measure the efficiency with which the mutant tau proteins found in frontotemporal dementia and Parkinsonism linked to chromosome 17 (FTDP-17) form filamentous structures. Several of these mutant proteins display enhanced polymerization in the presence of arachidonic acid, suggesting a direct role for these mutations in tau the filament formation that characterizes FTDP-17.
Bibliography:ark:/67375/TPS-ZDW0D7J4-7
istex:03CB45B12699D45F0EB2C453131CB5897B36BEF4
Supported by grants from the NIH (AG14453, AG14452, AG15307, AG15383) and the Alzheimer's Association (Zen-98-012, PRG-1709).
ISSN:0006-2960
1520-4995
DOI:10.1021/bi000201f